Methodological considerations for end-of-life research in patients with chronic kidney disease

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 268-282

  Davison, Sara N ^a,b   Murtagh, Fliss E M ^c   Higginson, Irene J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic kidney disease; End of life; Ethics; Methodology; Research

Indexed keywords

ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DECISION MAKING; DIALYSIS; DYING; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; METHODOLOGY; PAIN; PALLIATIVE THERAPY; PROGNOSIS; QUESTIONNAIRE; RESEARCH ETHICS; TERMINAL CARE; TREATMENT REFUSAL; CHRONIC KIDNEY FAILURE; ECONOMICS; HEALTH SERVICES RESEARCH; MEDICAL ETHICS; REVIEW;

ETHICS, MEDICAL; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; KIDNEY FAILURE, CHRONIC; PALLIATIVE CARE; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RESEARCH DESIGN; TERMINAL CARE;

EID: 52049122646     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (142)

1. Germain MJ, Cohen LM, Davison SN. Withholding and withdrawal from dialysis: what we know about how our patients die. Semin Dial. 2007;20:195-199.
2. Canadian Institute for Health Information. Canadian Organ Replacement Registry: Dialysis and Renal Transplantation. Ottawa, ON: Canadian Institute for Health Information; 2002.
3. US Renal Data System. USRDS: 2004 Annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2007;49(Suppl 1):S1-S239.
4. Murray AM, Arko C, Chen SC, Gilbertson DT, Moss AH. Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol. 2006;1:1248-1255.
5. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42:1239-1247.
6. Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 2006;69:1621-1625.
7. Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006;21:3189-3195.
8. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16:2487-2494.
9. Weisbord SD, Carmody SS, Bruns FJ, et al. Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. Nephrol Dial Transplant. 2003;18:1345-1352.
10. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14:82-99.
11. Fainsinger R, Davison SN, Brenneis C. A supportive care model for dialysis patients. Palliat Med. 2003;17:81-82.
12. Chater S, Davison SN, Germain MJ, Cohen LM. Withdrawal from dialysis: a palliative care perspective. Clin Nephrol. 2006;66:364-372.
13. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007;10:1266-1276.
14. Holley JL, Davison SN, Moss AH. Nephrologists' changing practices in reported end-of-life decision-making. Clin J Am Soc Nephrol. 2007;2:107-111.
15. Davison SN. Facilitating advance care planning for patients with end-stage renal disease: the patient perspective. Clin J Am Soc Nephrol. 2006;1:1023-1028.
16. Davison SN, Jhangri GS, Holley JL, Moss AH. Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol. 2006;1:1256-1262.
17. Lohr KN. Medicare: A Strategy for Quality Assurance. Washington, DC: National Academies Press; 1990.
18. Donabedian A. The Definition of Quality and Approaches to Its Assessment: Explorations in Quality Assessment and Monitoring. Ann Arbor, MI: Health Administration Press; 1980.
19. National Consensus Project. Clinical Practice Guidelines for Palliative Care. National Consensus Project 2004. http://www.nationalconsensusproject.org/. Accessed March 20, 2008.
20. National Hospice and Palliative Care Organization. Standards of Practice for Hospice Programs. National Hospice and Palliative Care Organization 2008. http://www.nhpco.org/templates/1/homepage.cfm. Accessed March 20, 2008.
21. Singer PA, Wolfson M. The best places to die. BMJ. 2003;327:173-174.
22. Singer PA, Bowman KW. Quality care at the end of life. BMJ. 2002;324:1291-1292.
23. Higginson IJ, Bruera E. Do we need palliative care audit in developing countries? Palliat Med. 2002;16:546-547.
24. Donabedian A. The seven pillars of quality. Arch Pathol Lab Med. 1990;114:1115-1118.
25. Health Services Research Group. Quality of care: what is quality and how can it be measured? CMAJ. 1992;146:2153-2158.
26. Committee on Quality of Health Care in America IoM. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
27. Executive NHS. The White Paper: The New NHS Modern and Dependable: A National Framework for Assessing Performance. London: Department of Health; 1998.
28. Ferrell BR. Overview of the domains of variables relevant to end-of-life care. J Palliat Med. 2005;8(Suppl 1):S22-S29.
29. Barnsley J, Lemieux-Charles L, Baker GR. Selecting clinical outcome indicators for monitoring quality of care. Health Manage Forum. 1996;9:5-21.
30. Ingleton C, Faulkner A. Quality assurance in palliative care: some of the problems. Eur J Cancer Care (Engl). 1995;4:38-44.
31. Meyer GS, Massagli MP. The forgotten component of the quality triad: can we still learn something from "structure"? Jt Comm J Qual Improv. 2001;27:484-493.
32. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326:816-819.
33. Morrison RS, Siu AL, Leipzig RM, Cassel CK, Meier DE. The hard task of improving the quality of care at the end of life. Arch Intern Med. 2000;160:743-747.
34. National Institutes of Health state-of-the-science conference statement: improving end-of-life care, December 6-8, 2004. J Pain Palliat Care Pharmacother. 2005;19:75-83.
35. Engelberg RA. Measuring the quality of dying and death: methodological considerations and recent findings. Curr Opin Crit Care. 2006;12:381-387.
36. Nelson JE, Danis M. End-of-life care in the intensive care unit: where are we now? Crit Care Med. 2001;29(Suppl):N2-N9.
37. Curtis JR. The "patient-centered" outcomes of critical care: what are they and how should they be used? New Horiz. 1998;6:26-32.
38. Curtis JR, Engelberg RA. Measuring success of interventions to improve the quality of end-of-life care in the intensive care unit. Crit Care Med. 2006;34(Suppl):S341-S347.
39. Higginson I. Clinical Audit in Palliative Care. Oxford: Radcliffe Medical Press; 1993.
40. Higginson IJ, McCarthy M. Validity of the support team assessment schedule: do staffs' ratings reflect those made by patients or their families? Palliat Med. 1993;7:219-228.
41. Singer PA, Martin DK, Kelner M. Quality end-of-life care. Patients' perspectives. JAMA. 1999;281:163-168.
42. Bowman KW, Martin DK, Singer PA. Quality end-of-life care. J Eval Clin Pract. 2000;6:51-61.
43. Moss AH. Measuring the quality of dying. J Palliat Med. 2001;4:149-151.
44. Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA. In search of a good death: observations of patients, families and providers. Ann Intern Med. 2000;132:825-832.
45. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre LM, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284:2476-2482.
46. Casarett DJ, Teno J, Higginson I. How should nations measure the quality of end-of-life care for older adults? Recommendations for an international minimum data set. J Am Geriatr Soc. 2006;54:1765-1771.
47. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666-674.
48. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133-1138.
49. Grunfeld E, Lethbridge L, Dewar R, et al. Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med. 2006;20:769-777.
50. Li SQ, Cass A, Cunningham J. Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports. Aust N Z J Public Health. 2003;27:419-424.
51. Rocco MV, Yan G, Gassman J, et al. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. Am J Kidney Dis. 2002;39:146-153.
52. Perneger TV, Klag MJ, Whelton PK. Cause of death in patients with end-stage renal disease: death certificates vs registry reports. Am J Public Health. 1993;83:1735-1738.
53. Teno JM, Clarridge B, Casey V, Edgman-Levitan S, Fowler J. Validation of Toolkit After-Death Bereaved Family Member Interview. J Pain Symptom Manage. 2001;22:752-758.
54. Connor SR, Teno J, Spence C, Smith N. Family evaluation of hospice care: results from voluntary submission of data via website. J Pain Symptom Manage. 2005;30:9-17.
55. Steinhauser KE, Clipp EC, Tulsky JA. Evolution in measuring the quality of dying. J Palliat Med. 2002;5:407-414.
56. Teno JM. Measuring end-of-life care outcomes retrospectively. J Palliat Med. 2005;8(Suppl 1):S42-S49.
57. Addington-Hall J, McPherson C. After-death interviews with surrogates/ bereaved family members: some issues of validity. J Pain Symptom Manage. 2001;22:784-790.
58. Lobchuk MM, Degner LF. Symptom experiences: perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting. J Clin Oncol. 2002;20:3495-3507.
59. Kapo J, Harrold J, Carroll JT, Rickerson E, Casarett D. Are we referring patients to hospice too late? Patients' and families' opinions. J Palliat Med. 2005;8:521-527.
60. Hinton J. How reliable are relatives' retrospective reports of terminal illness? Patients and relatives' accounts compared. Soc Sci Med. 1996;43:1229-1236.
61. McPherson CJ, Addington-Hall JM. Judging the quality of care at the end of life: can proxies provide reliable information? Soc Sci Med. 2003;56:95-109.
62. Engelberg RA, Patrick DL, Curtis JR. Correspondence between patients' preferences and surrogates' understandings for dying and death. J Pain Symptom Manage. 2005;30:498-509.
63. Curtis JR, Patrick DL, Engelberg RA, Norris K, Asp C, Byock I. A measure of the quality of dying and death. Initial validation using after-death interviews with family members. J Pain Symptom Manage. 2002;24:17-31.
64. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88-93.
65. Lynn J, Teno JM, Phillips RS, et al; SUPPORT Investigators. Perceptions by family members of the dying experience of older and seriously ill patients: study to understand prognoses and preferences for outcomes and risks of treatment. Ann Intern Med. 1997;126:97-106.
66. Casarett DJ, Crowley RL, Hirschman KB. How should clinicians describe hospice to patients and families? J Am Geriatr Soc. 2004;52:1923-1928.
67. Tilden VP, Tolle S, Drach L, Hickman S. Measurement of quality of care and quality of life at the end of life. Gerontologist. 2002;42:71-80.
68. Steinhauser KE. Measuring end-of-life care outcomes prospectively. J Palliat Med. 2005;8(Suppl 1):S30-S41.
69. Cohen LM, Germain MJ. Measuring quality of dying in end-stage renal disease. Semin Dial. 2004;17:376-379.
70. Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage. 2004;27:226-240.
71. Patrick DL, Curtis JR, Engelberg RA, Nielsen E, McCown E. Measuring and improving the quality of dying and death. Ann Intern Med. 2003;139:410-415.
72. Aspinal F, Hughes R, Higginson IJA. User's Guide to the Palliative Care Outcome Scale. London: Palliative Care and Policy Publications; 2002.
73. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med. 1997;11:3-20.
74. Cartwright A, Hockey L, Anderson JL. Life before death. London: Routledge and Kegan Paul; 1973.
75. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006;333:886.
76. Earle CC, Ayanian JZ. Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol. 2006;24:838-840.
77. Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004;292:2765-2770.
78. Murtagh F, Cohen LM, Germain MJ. Dialysis discontinuation: quo vadis? Adv Chronic Kidney Dis. 2007;14:379-401.
79. Moss AH, Ganjoo J, Sharma S, et al. Utility of the "surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008 (in press).
80. Baker ME. Economic, political and ethnic influences on end-of-life decision-making: a decade in review. J Health Soc Policy. 2002;14:27-39.
81. Hopp FP, Duffy SA. Racial variations in end-of-life care. J Am Geriatr Soc. 2000;48:658-663.
82. Singer PA, Thiel EC, Naylor DC, et al. Life-sustaining treatment preferences of hemodialysis patients: Implications for advanced directives. J Am Soc Nephrol. 1995;6:1410-1417.
83. Kaufert JM, Putsch RW, Lavallee M. End-of-life decision making among Aboriginal Canadians: interpretation, mediation, and discord in the communication of "bad news". J Palliat Care. 1999;15:31-38.
84. Newbold KB. Disability and use of support services within the Canadian aboriginal population. Health Soc Care Community. 1999;7:291-300.
85. Bowman KW, Hui EC. Bioethics for clinicians: 20. Chinese bioethics. CMAJ. 2000;163:1481-1485.
86. Witherspoon G. Language and Art in the Navajo Universe. Ann Arbor, MI: University of Michigan Press; 1977.
87. Davison SN, Holley JL. Ethical issues in the care of vulnerable chronic kidney disease patients: the elderly, cognitively impaired, and those from different cultural backgrounds. Adv Chronic Kidney Dis. 2008;15:177-185.
88. Port FK, Wolfe RA, Hawthorne VM, Ferguson CW. Discontinuation of dialysis therapy as a cause of death. Am J Nephrol. 1989;9:145-149.
89. Wilkie P. Ethical issues in qualitative research in palliative care. Palliat Med. 1997;11:321-324.
90. Henderson M, Addington-Hall JM, Hotopf M. The willingness of palliative care patients to participate in research. J Pain Symptom Manage. 2005;29:116-118.
91. Emanuel EJ, Fairclough DL, Wolfe P, Emanuel LL. Talking with terminally ill patients and their caregivers about death, dying, and bereavement: is it stressful? Is it helpful? Arch Intern Med. 2004;164:1999-2004.
92. The AM, Hak T, Koeter G, van Der WG. Collusion in doctor-patient communication about imminent death: an ethnographic study. BMJ. 2000;321:1376-1381.
93. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289:2387-2392.
94. Teno JM, Weitzen S, Fennell ML, Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med. 2001;4:457-464.
95. Covinsky KE, Eng C, Lui LY, Sands LP, Yaffe K. The last 2 years of life: functional trajectories of frail older people. J Am Geriatr Soc. 2003;51:492-498.
96. Romoren TI, Blekeseaune M. Trajectories of disability among the oldest old. J Aging Health. 2003;15:548-566.
97. Chin MH, Zhang JX, Rathouz PJ. Transitions in health status in older patients with heart failure. South Med J. 2003;96:1096-1106.
98. Hanrahan P, Raymond M, McGowan E, Luchins DJ. Criteria for enrolling dementia patients in hospice: a replication. Am J Hosp Palliat Care. 1999;16:395-400.
99. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295:801-808.
100. Lezzoni L. Risk Adjustment for Measuring Health Care Outcomes. 3rd ed. Chicago, IL: Health Administration Press; 2003.
101. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract. 2003;95:c40-c46.
102. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22:1955-1962.
103. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ. 1999;318:217-223.
104. Davison S. Quality end-of-life care in hemodialysis units. Semin Dial. 2002;15:1-4.
105. Bosshard G, Fischer S, Van Der HA, Miccinesi G, Faisst K. Intentionally hastening death by withholding or withdrawing treatment. Wien Klin Wochenschr. 2006;118:322-326.
106. Clement R, Chevalet P, Rodat O, Ould-Aoudia V, Berger M. Withholding or withdrawing dialysis in the elderly: the perspective of a western region of France. Nephrol Dial Transplant. 2005;20:2446-2452.
107. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14:1012-1021.
108. Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician speciality and education and patient functional status. Am J Kidney Dis. 1998;31:464-472.
109. McKenzie JK, Moss AH, Feest TG, Stocking CB, Siegler M. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis. 1998;31:12-18.
110. Pollini J, Teissier M. A difficult dilemma to resolve: aged patients refused for treatment by iterative hemodialysis. Ethical problem or medical choice? Reflections apropos of a questionnaire-inquiry. Nephrologie. 1990;11:341-347.
111. Lambie M, Rayner HC, Bragg-Gresham JL, et al. Starting and withdrawing haemodialysis: associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol Dial Transplant. 2006;21:2814-2820.
112. Calvin AO. Haemodialysis patients and end-of-life decisions: a theory of personal preservation. J Adv Nurs. 2004;46:558-566.
113. Ashby M, op't Hoog C, Kellehear A, et al. Renal dialysis abatement: lessons from a social study. Palliat Med. 2005;19:389-396.
114. Fujimaki H, Kasuya Y, Kawaguchi S, et al. Refusal of initiation of dialysis by elderly patients with chronic renal failure. Nippon Ronen Igakkai Zasshi. 2005;42:417-422.
115. Chan CH, Noble H, Lo SH, Kwan TH, Lee SL, Sze WK. Palliative care for patients with end-stage renal disease: experiences from Hong Kong. Int J Palliat Nurs. 2007;13:310-314.
116. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA. 1995;274:1591-1598.
117. Davison SN, Torgunrud C. The creation of an advance care planning process for patients with ESRD. Am J Kidney Dis. 2007;49:27-36.
118. Tolle SW, Tilden VP, Nelson CA, Dunn PM. A prospective study of the efficacy of the physician order form for life-sustaining treatment. J Am Geriatr Soc. 1998;46:1097-1102.
119. Hickman SE, Hammes BJ, Moss AH, Tolle SW. Hope for the future: achieving the original intent of advance directives. Hastings Cent Rep. 2005;Spec No:S26-S30.
120. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005;30:465-473.
121. O'Donnell K, Chung JY. The diagnosis of major depression in end-stage renal disease. Psychother Psychosom. 1997;66:38-43.
122. Smith MD, Hong BA, Robson AM. Diagnosis of depression in patients with end-stage renal disease: comparative analysis. Am J Med. 1985;79:160-166.
123. Mukamel DB, Bajorska A, Temkin-Greener H. Health care services utilization at the end of life in a managed care program integrating acute and long-term care. Med Care. 2002;40:1136-1148.
124. Emanuel EJ, Emanuel LL. The economics of dying: the illusion of cost savings at the end of life. N Engl J Med. 1994;330:540-544.
125. Medicare Payment Advisory Commission (Med-PAC). Improving Care at the End of Life. Report to the Congress: Selected Medicare Issues. Medicare Payment Advisory Commission (Med-PAC); 1999. Washington, DC: National Academy Press; 1999.
126. Menec VH, Lix L, Nowicki S, Ekuma O. Health care use at the end of life among older adults: does it vary by age? J Gerontol A Biol Sci Med Sci. 2007;62:400-407.
127. Smith TJ, Coyne P, Cassel B, Penberthy L, Hopson A, Hager MA. A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med. 2003;6:699-705.
128. Mor V, Kidder D. Cost savings in hospice: final results of the National Hospice Study. Health Serv Res. 1985;20:407-422.
129. Kidder D. The effects of hospice coverage on Medicare expenditures. Health Serv Res. 1992;27:195-217.
130. Kane RL, Berstein L, Wales J, Rothenberg R. Hospice effectiveness in controlling pain. JAMA. 1985;253:2683-2686.
131. Kane RL, Wales J, Bernstein L, Leibowitz A, Kaplan S. A randomised controlled trial of hospice care. Lancet. 1984;1:890-894.
132. Greer DS, Mor V, Morris JN, Sherwood S, Kidder D, Birnbaum H. An alternative in terminal care: results of the National Hospice Study. J Chronic Dis. 1986;39:9-26.
133. Goldberg RJ, Mor V, Wiemann M, Greer DS, Hiris J. Analgesic use in terminal cancer patients: report from the National Hospice Study. J Chronic Dis. 1986;39:37-45.
134. Gomez-Batiste X, Tuca A, Corrales E, et al. Resource consumption and costs of palliative care services in Spain: a multicenter prospective study. J Pain Symptom Manage. 2006;31:522-532.
135. Campbell DE, Lynn J, Louis TA, Shugarman LR. Medicare program expenditures associated with hospice use. Ann Intern Med. 2004;140:269-277.
136. Emanuel EJ, Ash A, Yu W, et al. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med. 2002;162:1722-1728.
137. Pronovost P, Angus DC. Economics of end-of-life care in the intensive care unit. Crit Care Med. 2001;29(Suppl):N46-N51.
138. Angus DC, Rubenfeld GD, Roberts MS. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society Workshop on Outcomes Research. Am J Respir Crit Care Med. 2002;165:540-550.
139. Bryce CL, Loewenstein G, Arnold RM, Schooler J, Wax RS, Angus DC. Quality of death: assessing the importance placed on end-of-life treatment in the intensive-care unit. Med Care. 2004;42:423-431.
140. Covinsky KE, Landefeld CS, Teno J, et al; SUPPORT Investigators. Is economic hardship on the families of the seriously ill associated with patient and surrogate care preferences? Arch Intern Med. 1996;156:1737-1741.
141. Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL. Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers. Ann Intern Med. 2000;132:451-459.
142. Covinsky KE, Goldman L, Cook EF, et al; SUPPORT Investigators. The impact of serious illness on patients' families. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. JAMA. 1994;272:1839-1844.